Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, announced the full integration of…
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress CareDx, Inc. The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…
Nomic and Wellcome Sanger Institute Collaborate to Bring Protein-Level Resolution to the Genetics of Immune Diversity Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC)…
Osmo To Sell 10 Proprietary AI-Developed Fragrance Ingredients In First-of-its-Kind Auction Osmo, the olfactory technology company, announced the first-ever auction of fragrance captives, offering exclusive, perpetual licenses to 10 proprietary molecules developed through its Olfactory Intelligence platform. Launching at the…
Komodo Health Evolves Leadership Structure and Names Miles Ennis President Komodo Health®, the leader in AI-powered healthcare intelligence, announced an evolution of its executive leadership structure to accelerate the company’s next phase of growth and reinforce its position as the…
Gurobi’s Research Leadership Recognized Across Leading Scientific Organizations Gurobi Optimization, LLC, the leader in decision intelligence technology, announced recognitions received by Dr. Edward Rothberg and Dr. Andreas Wächter from leading academic and industry organizations for research that has had lasting…
Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner covering biology and chemistry Pelago Bioscience, a contract research organization (CRO) specializing in drug discovery and renowned for its cutting-edge cell target engagement assays, is pleased to announce the…
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results PURE Bioscience, Inc. creator of the patented non-toxic silver dihydrogen citrate antimicrobial, reported financial results for the fiscal third quarter ended April 30, 2026. Summary of Results of Operations – Third Quarter…
cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA)…
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1 Takeda presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective…
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit BeOne Medicines Ltd. a global oncology company, announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small…
Deutsche Aircraft and Hexcel Announce Long‑Term Composite Partnership for the D328eco ® Regional Aircraft Program Deutsche Aircraft and Hexcel Corporation jointly announced the signing of a long‑term industrial partnership and supply agreement focused on advanced composite solutions for the D328eco, the next‑generation…